Acts Online
GT Shield

Compensation for Occupational Injuries and Diseases Act, 1993 (Act No. 130 of 1993)


Directive on Compensation for Workplace-acquired Novel Corona Virus Disease (COVID-19)

Schedule A : Circular No. CF/06/2020

2. Definition


2.1 This Directive deals with workplace-acquired COVID-19 resulting from work-related exposures; exposure to suspected or confirmed case(s) of COVID-19 in the workplace; or while travelling on an official trip to high-risk countries or areas on work assignment or while performing any duty in pursuance of the employer's business.


2.2. In this Directive, any word or expression to which a meaning has been assigned in the Act shall bear that meaning and, unless the context otherwise indicates—


2.2.1. "Coronavirus Disease (COVID-19)"

means a viral infection of the upper respiratory system which presents with flu-like symptoms ranging from mild fever, dry cough, runny nose, sneezing to persistent symptoms such as productive cough, high fever, shortness of breath and general malaise. In its severe form, it can present with pneumonia, acute respiratory distress syndrome (ARDS), systemic inflammation and multiorgan failure. It is transmitted through droplets during coughing and sneezing from an infected person or as a result of contact with coronavirus contaminated surface.


2.2.2. "Workplace"

means workplace as defined in section 213 of the Labour Relations Act, 1996 (Act No. 66 of 1995).


2.2.3. "Workplace-acquired COVID-19"

refers to an instance where an employee, as defined in the COID Act, contracts COVID-19 whilst carrying out his or her duties.


2.3. A claim for workplace-acquired COVID-19 shall clearly be set out as contemplated in and provided for in section 65 of the COID Act.